<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>At the age of 20 years, a Japanese man with <z:e sem="disease" ids="C0554021" disease_type="Disease or Syndrome" abbrv="">recurrent oral aphthae</z:e>, <z:hpo ids='HP_0003249'>genital ulcers</z:hpo>, <z:mp ids='MP_0000376'>folliculitis</z:mp>, <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum, episodic <z:hpo ids='HP_0001369'>arthritis</z:hpo> and <z:hpo ids='HP_0000031'>epididymitis</z:hpo> was diagnosed as having <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) in 1966 </plain></SENT>
<SENT sid="1" pm="."><plain>He has had active ocular manifestations of BD since 1990 </plain></SENT>
<SENT sid="2" pm="."><plain>These symptoms recurred and never abated for a long period of time </plain></SENT>
<SENT sid="3" pm="."><plain>A right <z:hpo ids='HP_0005584'>renal cell carcinoma</z:hpo> developed and he underwent right nephrectomy in April 1996 </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment with interferon-alpha was started from June 1996 as supplemental chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>No active phase developed during administration of IFN-alpha </plain></SENT>
<SENT sid="6" pm="."><plain>We suggest that IFN-alpha may play a role as an immunomodulatory agent in BD </plain></SENT>
</text></document>